A new lipid technology for antiseptic emollient products
Formulations can be delivered as spray, drop, solution, medical wipe or dermal patch.and offer non-touch applications.
Emollients help the skin functions by reducing water loss from epidermis through a protective layer. For dry or irritated skin and conditions such as eczema, emollients are an essential part of daily skin care. In addition, antiseptic emollients reduce the possibility of infection which might worsen skin conditions.
Akvano technology formulations are inherently antiseptic without any added antimicrobial substances. The high alcohol content in combination with natural lipid ingredients make the Akvano solutions unique antiseptic emollients. The alcohol destroys bacteria on the skin surface before evaporating and the dissolved lipids form an protective non-occlusive layer which prevents water loss and restores the skin barrier.
Lipids occur in all living matter as one of the main groups of biomolecules, together with amino acids, carbohydrates and nucleic acids. Lipids serve several purposes in the human body, including as energy reserves and as structural building blocks (biological membranes). Lipidor is focusing on exploiting the vast capabilities of these natural and endogenous lipids, and how they can be used in skin treatment both by themselves, and as delivery vehicles for active ingredients.
Akvano formulations are water-free and provide a direct lipid layer deposition on the skin – in contrast to conventional lipid formulations that form different types of dispersions (ointments, cream etc) which contain water. Formulations can be delivered as spray, drop, solution, medical wipe or dermal patch.and offer non-touch applications.
Akvano formulations consist of components well-known in dermatology applications, and are natural and free from preservatives and irritants:
Formulations consist of selected lipids, with or without active ingredients, that are dissolved in a volatile solvent, formulated as a clear cutaneous and sprayable liquid. The solvent quickly evaporates after having been applied to the affected site, leaving a thin, dry lipid layer on the skin surface, for skin care treatment and effective (non-systemic) delivery of active ingredients. The lipid layer immediately interacts with skin lipids and can start to exert their effect.
Akvano sprayable formulations offer advantages in key areas:
Lipidor is establishing licensing arrangements with co-development partners and distributors for skin and wound care, disinfection and animal care products. Products can be purchased ready and packaged products, with or without exclusivity for a specific market. Co-development of products is also an option.
Related News
-
News US BIOSECURE Act passed by US House of Representatives
The controversial act, which has already impacted several foreign companies operating in the US, was passed by the House of Representatives on September 9, 2024. It is now headed for the US Senate before it can be signed into law by President Joe Biden... -
News Pharma Supply Chain People Moves
The latest appointments, promotions, and structural changes across the pharmaceutical supply chain. -
News Drug prices agreed upon as part of the US Inflation Reduction Act
The Inflation Reduction Act brought into constitution by the Biden administation in 2022, which proposed a drug price negotiation between the government and pharmaceutical companies, has reached it's first agreement. -
News BIOSECURE Act continues to loom over Chinese pharma manufacturers
With the US BIOSECURE Act on its way to passing into legislation, Chinese companies are facing declining revenues within the first half of 2024 as US pharmaceutical and healthcare companies pull their businesses from the country. -
News Ophthalmologic drug product Eylea faces biosimilar threats after FDA approvals
Regeneron Pharmaceutical’s blockbuster ophthalmology drug Eylea is facing biosimilar competition as the US FDA approves Biocon’s Yesafili and Samsung Bioepis/Biogen’s Opuviz. -
News ONO Pharmaceutical expands oncology portfolio with acquisition of Deciphera
ONO Pharmaceutical, out of Japan, is in the process of acquiring cancer-therapy maker Deciphera Pharmaceuticals for US$2.4 billion. -
News First offers for pharma from Medicare drug price negotiations
Ten high-cost drugs from various pharma manufacturers are in pricing negotiations in a first-ever for the US Medicare program. President Biden’s administration stated they have responded to the first round of offers. -
News Eli Lilly’s Zepbound makes leaps and bounds in weight-loss drug market
In the last week, Eli Lilly has announced their partnership with Amazon.com’s pharmacy unit to deliver prescriptions of Zepbound. Zepbound has also surpassed Novo Nordisk’s Wegovy for the number of prescriptions for the week of March 8.&nbs...
Position your company at the heart of the global Pharma industry with a CPHI Online membership
-
Your products and solutions visible to thousands of visitors within the largest Pharma marketplace
-
Generate high-quality, engaged leads for your business, all year round
-
Promote your business as the industry’s thought-leader by hosting your reports, brochures and videos within your profile
-
Your company’s profile boosted at all participating CPHI events
-
An easy-to-use platform with a detailed dashboard showing your leads and performance